Authors
Loading...
Review demonstrates the substantial global disease burden of hepatitis B virus across endemic populations, highlighting the critical need for expanded vaccination and advanced antiviral therapies.
Daniel Lavanchy (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: